BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3888113)

  • 21. Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum types C and D.
    Hauser D; Gibert M; Eklund MW; Boquet P; Popoff MR
    J Bacteriol; 1993 Nov; 175(22):7260-8. PubMed ID: 8226673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum neurotoxin type A: limited proteolysis by endoproteinase Glu-C and alpha-chymotrypsin enhanced following reduction; identification of the cleaved sites and fragments.
    Beecher DJ; DasGupta BR
    J Protein Chem; 1997 Oct; 16(7):701-12. PubMed ID: 9330228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum neurotoxin type E fragmented with endoproteinase Lys-C reveals the site trypsin nicks and homology with tetanus neurotoxin.
    Giménez JA; DasGupta BR
    Biochimie; 1990 Apr; 72(4):213-7. PubMed ID: 2116911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystallization and preliminary X-ray analysis of botulinum neurotoxin type A.
    Stevens RC; Evenson ML; Tepp W; DasGupta BR
    J Mol Biol; 1991 Dec; 222(4):877-80. PubMed ID: 1762156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.
    Watanabe T; Sagane Y; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Oct; 18(7):753-60. PubMed ID: 10691185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.
    Dasgupta BR; Sugiyama H
    Infect Immun; 1976 Sep; 14(3):680-6. PubMed ID: 965092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.
    Dekleva ML; Dasgupta BR
    J Bacteriol; 1990 May; 172(5):2498-503. PubMed ID: 2185224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments.
    Gimenez JA; DasGupta BR
    J Protein Chem; 1993 Jun; 12(3):351-63. PubMed ID: 8397793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.
    Kozaki S; Onimaru J; Kamata Y; Sakaguchi G
    Infect Immun; 1991 Jan; 59(1):457-9. PubMed ID: 1987060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single chain and dichain forms of neurotoxin in type F Clostridium botulinum culture.
    DasGupta BR; Sugiyama H
    Toxicon; 1977; 15(5):466-71. PubMed ID: 906033
    [No Abstract]   [Full Text] [Related]  

  • 32. The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene.
    Whelan SM; Elmore MJ; Bodsworth NJ; Atkinson T; Minton NP
    Eur J Biochem; 1992 Mar; 204(2):657-67. PubMed ID: 1541280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum neurotoxin type A: cleavage of the heavy chain into two halves and their partial sequences.
    Sathyamoorthy V; Dasgupta BR; Foley J; Niece RL
    Arch Biochem Biophys; 1988 Oct; 266(1):142-51. PubMed ID: 3178218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.
    Terajima J; Syuto B; Ochanda JO; Kubo S
    Infect Immun; 1985 May; 48(2):312-7. PubMed ID: 3988338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequencing and phylogenetic analysis of neurotoxin gene from an environmental isolate of Clostridium sp.: comparison with other clostridial neurotoxins.
    Dixit A; Alam SI; Singh L
    Arch Toxicol; 2006 Jul; 80(7):399-404. PubMed ID: 16474961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site.
    DasGupta BR; Dekleva ML
    Biochimie; 1990 Sep; 72(9):661-4. PubMed ID: 2126206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type A and B neurotoxin genes in a Clostridium botulinum type AB strain.
    Fujinaga Y; Takeshi K; Inoue K; Fujita R; Ohyama T; Moriishi K; Oguma K
    Biochem Biophys Res Commun; 1995 Aug; 213(3):737-45. PubMed ID: 7654232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y; Kimura Y; Hiroi T; Sakaguchi G; Kozaki S
    Biochim Biophys Acta; 1993 Feb; 1156(2):213-8. PubMed ID: 8427878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of nicking of the nontoxic-nonhemagglutinin components of Clostridium botulinum types C and D progenitor toxin.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 2000 Oct; 19(7):575-81. PubMed ID: 11233171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.